Discovery of new anticancer drugs by computer-aided drug design.
Determination of the three-dimensional molecular structures of proteins, enzymes and nucleic acids is the first step in the development of molecular models of drug-receptor complexes that may be used in the rational computer-aided design of new and sometimes novel inhibitors with altered recognition and receptor-affinity properties. This approach provides a rational method for developing drugs that may be highly selective for a particular oncogene or other protein targets.